Details for Patent: 12,048,769
✉ Email this page to a colleague
Which drugs does patent 12,048,769 protect, and when does it expire?
Patent 12,048,769 protects CONTRAVE and is included in one NDA.
This patent has nineteen patent family members in twelve countries.
Drugs Protected by US Patent 12,048,769
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200063-001 | Sep 10, 2014 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | USE OF NALTREXONE AND BUPROPION BASED ON AN ESCALATING DOSE SCHEDULE | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,048,769
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 063958 | ⤷ Sign Up | |||
| Australia | 2007319472 | ⤷ Sign Up | |||
| Canada | 2668885 | ⤷ Sign Up | |||
| Chile | 2007003246 | ⤷ Sign Up | |||
| China | 101573103 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
